Pantothenate Kinase-Associated Neurodegeneration
Showing 1 - 25 of >10,000
Pantothenate Kinase-Associated Neurodegeneration Trial (Deferiprone)
No longer available
- Pantothenate Kinase-Associated Neurodegeneration
- (no location specified)
Nov 9, 2022
Pantothenate Kinase-Associated Neurodegeneration Trial in Portland (CoA-Z, Placebo)
Active, not recruiting
- Pantothenate Kinase-Associated Neurodegeneration
- CoA-Z
- Placebo
-
Portland, OregonOregon Health & Science University
Jan 25, 2022
Testing of NBIA Genes: Analysis of Genetic Heterogeneity and
Completed
- Neurodegeneration With Brain Iron Accumulation (NBIA)
- Establishment of mitochondrial markers
- Sequencing tests
-
Talence, FranceCentre Hospitalier Universitaire de Bordeaux
Nov 7, 2022
Intellectual Disability, Rubinstein-Taybi Syndrome, Cystic Fibrosis Trial in Bordeaux (Ex-vivo approach concerning 25 patients,
Not yet recruiting
- Intellectual Disability
- +6 more
- Ex-vivo approach concerning 25 patients
- In-vitro approach concerning 25 patients
-
Bordeaux, FranceHopital Pellegrin
Jan 23, 2023
Pantothenate Kinase-Associated Neurodegeneration Trial in Worldwide (Deferiprone oral solution)
Completed
- Pantothenate Kinase-Associated Neurodegeneration
- Deferiprone oral solution
-
Oakland, California
- +3 more
Aug 12, 2020
Natural History Patient-reported Outcome Measures
Recruiting
- Neurodegeneration With Brain Iron Accumulation (NBIA)
-
Portland, OregonOregon Health & Science University
Oct 5, 2020
Pantothenate Kinase-Associated Neurodegeneration Trial in Worldwide (Fosmetpantotenate, Placebo)
Terminated
- Pantothenate Kinase-Associated Neurodegeneration
- Fosmetpantotenate
- Placebo
-
Irvine, California
- +19 more
Jan 7, 2021
Pantothenate Kinase-Associated Neurodegeneration Trial in Worldwide (Deferiprone oral solution, Placebo)
Completed
- Pantothenate Kinase-Associated Neurodegeneration
- Deferiprone oral solution
- Placebo
-
Oakland, California
- +3 more
Jun 27, 2019
Brain Perfusion in Pantothenate Kinase-associated
Completed
- Pantothenate Kinase-associated Neurodegeneration (PKAN)
-
Portland, OregonOregon Health & Science University
May 24, 2018
Phenotypic Description of Atypical Clinical Forms of PLA2G6
Enrolling by invitation
- Neuroaxonal Dystrophy, Atypical
-
Clermont-Ferrand, France
- +6 more
Jun 29, 2022
Imaging Neuromelanin and Iron in Dystonia/Parkinsonism
Unknown status
- Sporadic Dystonia
- +4 more
- 3Tesla MRI
- +4 more
- (no location specified)
Jun 27, 2018
Protection Response to Cellular Stress in BPAN's Patient Study
Not yet recruiting
- Children and Adults With BPAN Carrying Pathogenic Variants of WDR45
- BPAN Patients
-
Bron, FranceService de génétique - Laboratoire de Biologie Médicale Multi-Si
Jul 13, 2023
Parkinson Disease Trial in Roma (blood sample)
Recruiting
- Parkinson Disease
- blood sample
-
Roma, ItalyFlavia Torlizzi
Mar 13, 2023
X-Linked Retinitis Pigmentosa Trial in Meguro-ku (AAV5-hRKp.RPGR)
Not yet recruiting
- X-Linked Retinitis Pigmentosa
- AAV5-hRKp.RPGR
-
Meguro-ku, JapanNational Hospital Organization Tokyo Medical Center
Jun 23, 2023
Multiple Sclerosis, Magnetic Resonance Spectroscopy Trial (magnetic resonance spectroscopy)
Not yet recruiting
- Multiple Sclerosis
- Magnetic Resonance Spectroscopy
- magnetic resonance spectroscopy
- (no location specified)
Aug 3, 2022
Neurodegenerative Diseases Trial in Zürich (Auditory stimulation)
Recruiting
- Neurodegenerative Diseases
- Auditory stimulation
-
Zürich, Zurich, SwitzerlandUniversity Hospital Zurich, Neurology department
May 30, 2022
Exploring the Gut-Brain Axis in Ageing and Neurodegeneration
Recruiting
- Healthy
- +3 more
- Magnetic Resonance Imaging
- +5 more
-
Venice-Lido, Venice, Italy
- +2 more
Jul 5, 2023
Neurological Immune-related Adverse Events
Recruiting
- Neurological Disease
- Analysis of biomarkers and their correlation with clinical characteristics and outcome
-
Bron, FranceCentre de référence des syndromes neurologiques paranéoplasiques
Jul 28, 2023
Stroke Trial in Roma (tDCS, Conventional rehabilitative treatment)
Recruiting
- Stroke
- tDCS
- Conventional rehabilitative treatment
-
Roma, ItalyI.R.C.C.S. Fondazione Santa Lucia
Apr 20, 2023
Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary-progressive Multiple Sclerosis Trial in Belgium (Metformin
Not yet recruiting
- Multiple Sclerosis
- +2 more
- Metformin Hydrochloride 850 mg Oral Tablet
- Placebo
-
Brugge, Belgium
- +4 more
May 30, 2023
Resistance-associated Mutations in Metastatic Lung Cancer
Recruiting
- Lung Cancer
- Liquid biopsy
-
Monza, MB, ItalyFondazione IRCCS San Gerardo dei Tintori
Oct 10, 2023
Microglia Activation in Asthma
Recruiting
- Asthma
- Whole lung antigen challenge (WLAC)
- [18F]FEPPA
-
Madison, WisconsinUniversity of Wisconsin Madison
Jul 14, 2022
PreDiabetes, Aging Trial in Albuquerque (Metformin, Placebo Oral Tablet)
Completed
- PreDiabetes
- Aging
- Metformin
- Placebo Oral Tablet
-
Albuquerque, New MexicoUniversity of New Mexico Clincal & Translational Science Center
Feb 25, 2022
Parkinson Disease, Progressive Supranuclear Palsy Trial in France (7 Tesla MRI)
Not yet recruiting
- Parkinson Disease
- Progressive Supranuclear Palsy
- 7 Tesla MRI
-
Aix-en-Provence, France
- +5 more
Nov 24, 2023
MPAN Trial (Passive Stretching, Mobilization, Muscle strengthening)
Not yet recruiting
- MPAN
- Passive Stretching
- +3 more
- (no location specified)
Jan 20, 2023